These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 27103146)

  • 21. Transarterial Ethanol Ablation for Unresectable Hepatocellular Carcinoma: Analysis of Clinical and Tumor Outcomes.
    Yu SC; Hui EP; Tang P; Chan SK; Chu CC; Hui JW; Chan SL; Lee KF; Lai PB; Yeo W
    J Vasc Interv Radiol; 2016 May; 27(5):639-49. PubMed ID: 26803574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation.
    Sun AX; Cheng ZL; Wu PP; Sheng YH; Qu XJ; Lu W; Zhao CG; Qian GJ
    World J Gastroenterol; 2015 Mar; 21(10):2997-3004. PubMed ID: 25780298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
    Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
    J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?
    Golfieri R; Renzulli M; Mosconi C; Forlani L; Giampalma E; Piscaglia F; Trevisani F; Bolondi L;
    J Vasc Interv Radiol; 2013 Apr; 24(4):509-17. PubMed ID: 23428355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter Phase II Clinical Trial of Sorafenib Combined with Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinomas (Barcelona Clinic Liver Cancer Stage C): STAB Study.
    Sato Y; Nishiofuku H; Yasumoto T; Nakatsuka A; Matsuo K; Kodama Y; Okubo H; Abo D; Takaki H; Inaba Y; Yamakado K
    J Vasc Interv Radiol; 2018 Aug; 29(8):1061-1067. PubMed ID: 29934260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors.
    Chern MC; Chuang VP; Liang CT; Lin ZH; Kuo TM
    J Vasc Interv Radiol; 2014 Jan; 25(1):32-40. PubMed ID: 24290099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis.
    Abdelaziz AO; Nabeel MM; Elbaz TM; Shousha HI; Hassan EM; Mahmoud SH; Rashed NA; Ibrahim MM; Abdelmaksoud AH
    Scand J Gastroenterol; 2015 Apr; 50(4):479-84. PubMed ID: 25592058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408
    [No Abstract]   [Full Text] [Related]  

  • 30. Korean Multicenter Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolic Agents for Nodular Hepatocellular Carcinomas: Six-Month Outcome Analysis.
    Lee M; Chung JW; Lee KH; Won JY; Chun HJ; Lee HC; Kim JH; Lee IJ; Hur S; Kim HC; Kim YJ; Kim GM; Joo SM; Oh JS
    J Vasc Interv Radiol; 2017 Apr; 28(4):502-512. PubMed ID: 27856136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A).
    Lee H; Yoon CJ; Seong NJ; Jeong SH; Kim JW
    Korean J Radiol; 2018; 19(6):1130-1139. PubMed ID: 30386144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J; Zheng JS; Sun B; Lu N
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma: Does the Degree of Ethiodized Oil Accumulation within the Tumor Affect the Therapeutic Efficacy?
    Lee JE; Kim JW; Kim HO; Lee BC; Hur YH; Cho SB; Cho YS; Seon HJ; Kim D
    J Vasc Interv Radiol; 2019 Mar; 30(3):370-379.e4. PubMed ID: 30819479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma.
    Kim HD; An J; Kim JH; Gwon DI; Shin JH; Ko GY; Yoon HK; Sung KB; Kim KM; Lee HC
    J Vasc Interv Radiol; 2016 Apr; 27(4):504-13. PubMed ID: 26896049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden.
    Ronot M; Cauchy F; Gregoli B; Breguet R; Allaham W; Paradis V; Soubrane O; Vilgrain V
    HPB (Oxford); 2016 Aug; 18(8):684-90. PubMed ID: 27485063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study.
    Huang YH; Park BV; Chen YF; Gaba RC; Guzman G; Lokken RP
    J Vasc Interv Radiol; 2019 Sep; 30(9):1317-1324. PubMed ID: 31375450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Hepatocellular Carcinoma with Tumor Thrombus with the Use of Iodine-125 Seed Strand Implantation and Transarterial Chemoembolization: A Propensity-Score Analysis.
    Zhang ZH; Zhang W; Gu JY; Liu QX; Ma JQ; Liu LX; Wang JH; Luo JJ; Yan ZP
    J Vasc Interv Radiol; 2018 Aug; 29(8):1085-1093. PubMed ID: 29754851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study.
    Yu SC; Hui EP; Wong J; Wong H; Mo F; Ho SS; Wong YY; Yeo W; Lai PB; Chan AT; Mok TS
    J Vasc Interv Radiol; 2008 Jan; 19(1):95-103. PubMed ID: 18192473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.